Spots Global Cancer Trial Database for cancerscan™
Every month we try and update this database with for cancerscan™ cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy | NCT02638428 | Relapsed Pediat... Refractory Pedi... Relapsed Pediat... Refractory Pedi... | CancerSCAN™ Ifosfamide Carboplatin Etoposide Fludarabine Cytarabine Pazopanib Sorafenib Axitinib Crizotinib Dasatinib Erlotinib Everolimus Imatinib Ruxolitinib Vandetanib Vemurafenib Trastuzumab | - 18 Years | Samsung Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
